Details for Patent: 6,074,666
✉ Email this page to a colleague
Summary for Patent: 6,074,666
Title: | Liposome compositions of porphyrin photosensitizers |
Abstract: | Liposomal pharmaceutical formulations incorporating porphyrin photosensitizers useful for photodynamic therapy or diagnosis of malignant cells. The liposomal formulations comprise a porphyrin photosensitizer, particularly the hydro-mono benzoporphyrins (BPD) having light absorption maxima in the range of 670-780 nanometers, a disaccharide or polysaccharide and one or more phospholipids. |
Inventor(s): | Desai; Narendra Raghunathji (Danbury, CT), Agha; Bushra J. (Durham, NC), Kale; Kalidas Madhavrao (Harriman, NY) |
Assignee: | QLT Phototherapeutics, Inc. (CA) |
Application Number: | 08/489,850 |
Patent Claim Types: see list of patent claims | Formulation; Composition; |
Drugs Protected by US Patent 6,074,666
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,074,666
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 151984 | ⤷ Sign Up | |||
Canada | 2087902 | ⤷ Sign Up | |||
Germany | 69310014 | ⤷ Sign Up | |||
Denmark | 0569113 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |